Pharmaceuticals are an important class of micropollutants within the freshwater
environment. There is sufficient evidence of their impacts on exposed biota to warrant further …

Trigeminal neuralgia (TN) is a complex orofacial pain syndrome characterized by the
paroxysmal onset of pain attacks in the trigeminal distribution. The underlying mechanism …

Neuropathic pain, caused by a lesion or disease affecting the somatosensory system, affects
between 3 and 17% of the general population. The treatment of neuropathic pain is …

Trigeminal neuralgia (TN) is a rare but debilitating disorder characterized by excruciating
facial pain, with a higher incidence in women. Recent studies demonstrated that TN patients …

Several reports have shown that pharmaceuticals and personal care products (PPCPs) have
some negative effects on anaerobic digestion (AD), yet there are no convenient and efficient …

Tailor-made AAs are indispensable components of modern medicinal chemistry and are
becoming increasingly prominent in new drugs. In fact, about 30% of small-molecule …

Trigeminal neuralgia (TN), the most common craniofacial neuralgia, results in intense,
debilitating facial pain and can profoundly affect quality of life. In this article, the authors …

Trigeminal neuralgia (TN), the most common form of severe facial pain, may be confused
with an ill-defined persistent idiopathic facial pain (PIFP). Facial pain is reviewed and a …

Chronic pain is a major global health issue that affects all populations regardless of sex,
age, ethnicity/race, or country of origin, leading to persistent physical and emotional distress …

Trigeminal neuralgia (TN) is a severe facial pain disease of unknown cause and unclear
genetic background. To examine the existing knowledge about genetics in TN, we …